Literature DB >> 24026561

Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans.

Julia Szendroedi1, Kirti Kaul, Lisa Kloock, Klaus Straßburger, Albrecht Ingo Schmid, Marek Chmelik, Michaela Kacerovsky, Gertrud Kacerovsky-Bielesz, Thomas Prikoszovich, Attila Brehm, Martin Krssák, Stephan Gruber, Michael Krebs, Alexandra Kautzky-Willer, Ewald Moser, Giovanni Pacini, Michael Roden.   

Abstract

OBJECTIVE: Muscle insulin resistance has been implicated in the development of steatosis and dyslipidemia by changing the partitioning of postprandial substrate fluxes. Also, insulin resistance may be due to reduced mitochondrial function. We examined the association between mitochondrial activity, insulin sensitivity, and steatosis in a larger human population. RESEARCH DESIGN AND METHODS: We analyzed muscle mitochondrial activity from ATP synthase flux (fATP) and ectopic lipids by multinuclei magnetic resonance spectroscopy from 113 volunteers with and without diabetes. Insulin sensitivity was assessed from M values using euglycemic-hyperinsulinemic clamps and/or from oral glucose insulin sensitivity (OGIS) using oral glucose tolerance tests.
RESULTS: Muscle fATP correlated negatively with hepatic lipid content and HbA1c. After model adjustment for study effects and other confounders, fATP showed a strong negative correlation with hepatic lipid content and a positive correlation with insulin sensitivity and fasting C-peptide. The negative correlation of muscle fATP with age, HbA1c, and plasma free fatty acids was weakened after adjustment. Body mass, muscle lipid contents, plasma lipoproteins, and triglycerides did not associate with fATP.
CONCLUSIONS: The association of impaired muscle mitochondrial activity with hepatic steatosis supports the concept of a close link between altered muscle and liver energy metabolism as early abnormalities promoting insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24026561     DOI: 10.2337/dc13-1359

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  10 in total

1.  Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index.

Authors:  Andrea Tura; Gaetano Chemello; Julia Szendroedi; Christian Göbl; Kristine Færch; Jana Vrbíková; Giovanni Pacini; Ele Ferrannini; Michael Roden
Journal:  Diabetologia       Date:  2018-02-26       Impact factor: 10.122

Review 2.  Intracellular lipid accumulation and shift during diabetes progression.

Authors:  Peter Wolf; Yvonne Winhofer; Christian-Heinz Anderwald; Martin Krššák; Michael Krebs
Journal:  Wien Med Wochenschr       Date:  2014-07-22

Review 3.  NAFLD and diabetes mellitus.

Authors:  Herbert Tilg; Alexander R Moschen; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-12       Impact factor: 46.802

4.  Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial.

Authors:  Theresia Sarabhai; Lucia Mastrototaro; Sabine Kahl; Gidon J Bönhof; Marc Jonuscheit; Pavel Bobrov; Hisayuki Katsuyama; Rainer Guthoff; Martin Wolkersdorfer; Christian Herder; Sven G Meuth; Sven Dreyer; Michael Roden
Journal:  Diabetologia       Date:  2022-09-30       Impact factor: 10.460

Review 5.  Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease.

Authors:  Yifei Chen; Fuji Yang; Ying Chu; Zhihua Yun; Yongmin Yan; Jianhua Jin
Journal:  J Transl Med       Date:  2022-10-22       Impact factor: 8.440

Review 6.  Metabolically healthy and unhealthy obese--the 2013 Stock Conference report.

Authors:  D Samocha-Bonet; V D Dixit; C R Kahn; R L Leibel; X Lin; M Nieuwdorp; K H Pietiläinen; R Rabasa-Lhoret; M Roden; P E Scherer; S Klein; E Ravussin
Journal:  Obes Rev       Date:  2014-07-25       Impact factor: 9.213

7.  Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.

Authors:  Sulin Cheng; Petri Wiklund; Reija Autio; Ronald Borra; Xiaowei Ojanen; Leiting Xu; Timo Törmäkangas; Markku Alen
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

8.  Cohort profile: the German Diabetes Study (GDS).

Authors:  Julia Szendroedi; Aaruni Saxena; Katharina S Weber; Klaus Strassburger; Christian Herder; Volker Burkart; Bettina Nowotny; Andrea Icks; Oliver Kuss; Dan Ziegler; Hadi Al-Hasani; Karsten Müssig; Michael Roden
Journal:  Cardiovasc Diabetol       Date:  2016-04-07       Impact factor: 9.951

9.  Insulin Resistance Is Associated With Reduced Mitochondrial Oxidative Capacity Measured by 31P-Magnetic Resonance Spectroscopy in Participants Without Diabetes From the Baltimore Longitudinal Study of Aging.

Authors:  Elisa Fabbri; Chee W Chia; Richard G Spencer; Kenneth W Fishbein; David A Reiter; Donnie Cameron; Ariel C Zane; Zenobia A Moore; Marta Gonzalez-Freire; Marco Zoli; Stephanie A Studenski; Rita R Kalyani; Josephine M Egan; Luigi Ferrucci
Journal:  Diabetes       Date:  2016-10-13       Impact factor: 9.461

10.  Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus.

Authors:  Peter Wolf; Paul Fellinger; Lorenz Pfleger; Sabina Smajis; Hannes Beiglböck; Martin Gajdošík; Christian-Heinz Anderwald; Siegfried Trattnig; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.